Dent, S., Moore, H., Fradley, M., Rose, C. G., Stergiopoulos, S., Chen, C., . . . Guha, A. QT STAR: Concomitant QTc-prolonging medication use among patients with HR+/HER2− metastatic breast cancer receiving a CDK4/6 inhibitor in first line. BMC.
Chicago Style (17th ed.) CitationDent, Susan, Heather Moore, Michael Fradley, Chloe Grace Rose, Stella Stergiopoulos, Connie Chen, Benjamin Li, and Avirup Guha. QT STAR: Concomitant QTc-prolonging Medication Use Among Patients with HR+/HER2− metastatic Breast Cancer Receiving a CDK4/6 Inhibitor in First Line. BMC.
MLA (9th ed.) CitationDent, Susan, et al. QT STAR: Concomitant QTc-prolonging Medication Use Among Patients with HR+/HER2− metastatic Breast Cancer Receiving a CDK4/6 Inhibitor in First Line. BMC.
Warning: These citations may not always be 100% accurate.